Walleye Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Walleye Trading’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$237K	Sell	1,428 -1,069	-43%	-$175K	﹤0.01%	3019
2025 Q4	$398K	Buy	+2,497	New	+$343K	﹤0.01%	2974
2022 Q1	–	Sell	-4	Closed	-$3K	–	5624
2021 Q4	$3K	Buy	+4	New	+$3.83K	﹤0.01%	5237
2019 Q3	–	Sell	-20	Closed	-$20K	–	4220
2019 Q2	$20K	Buy	+20	New	+$19.4K	﹤0.01%	3744
2019 Q1	–	Sell	-40	Closed	-$41.6K	–	4492
2018 Q4	$26K	Sell	40 -55	-58%	-$57.7K	﹤0.01%	4296
2018 Q3	$176K	Buy	+95	New	+$187K	﹤0.01%	3852
2017 Q3	–	Sell	-78	Closed	-$108K	–	4380
2017 Q2	$99	Buy	78 +61	+359%	+$61.5K	﹤0.01%	3552
2017 Q1	$16	Buy	+17	New	+$15.1K	﹤0.01%	4208
2016 Q4	–	Sell	-68	Closed	-$51.1K	–	4948
2016 Q3	$66K	Buy	+68	New	+$56.1K	﹤0.01%	3581

Other funds holding LABU

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Walleye Trading's LABU Position: Q1 2026 in Review

Walleye Trading reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 43% in Q1 2026, selling an estimated $175K and leaving 1,428 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #3019.

Walleye Trading first reported a position in LABU in Q3 2016 and has held it in 9 quarters since. The position peaked at $398K in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

Walleye Trading held 1,428 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $237K as of Q1 2026.
Walleye Trading sold 1,069 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $175K.
Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3019 holding.
Walleye Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2016 and has held it in 9 quarters since.
Walleye Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $398K in Q4 2025.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.